V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003261 | 280002446 | 1.74 | 48.9 | null | 2016-03-06 | 2016-03-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025271 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003262 | 280002447 | 1.73 | 61.7 | Curative (C) | 2015-05-30 | 2015-06-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025272 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003263 | 280002448 | null | 46.8 | Neo-adjuvant (N) | 2017-09-08 | 2017-09-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025273 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003264 | 280002448 | 1.76 | null | Curative (C) | null | 2013-12-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025273 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003265 | 280002449 | 1.71 | null | Curative (C) | null | 2015-06-02 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025275 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003266 | 280002449 | 1.76 | 64.2 | Neo-adjuvant (N) | 2016-04-05 | 2016-05-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025275 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003267 | 280002450 | 1.67 | null | null | null | 2014-12-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280025279 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003268 | 280007272 | 1.78 | 88.2 | Neo-adjuvant (N) | 2017-09-20 | 2017-10-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025280 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003269 | 280009719 | 1.84 | 82.6 | Palliative (P) | 2016-08-21 | 2016-10-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025283 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003270 | 280002451 | 1.68 | 91.3 | Not known (9) | 2016-08-13 | 2016-08-13 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280025284 | CISPLATIN + FLUOROURACIL |
| 280003271 | 280002452 | 1.83 | 108 | null | null | 2013-10-11 | Cetuximab + Radiotherapy Maint | null | null | 280025287 | CETUXIMAB + RT |
| 280003272 | 280002453 | 1.53 | 122.8 | Curative (C) | null | 2015-02-28 | CETUXIMAB + RT | null | Y | 280025289 | CETUXIMAB + RT |
| 280003273 | 280002454 | 1.75 | null | Neo-adjuvant (N) | 2015-08-26 | 2015-08-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025290 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003274 | 280002455 | 1.58 | 98.9 | Neo-adjuvant (N) | 2016-12-26 | 2016-12-28 | Doxorubicin + Ifosfamide | 02 | null | 280025291 | DOXORUBICIN + IFOSFAMIDE |
| 280003275 | 280002456 | 1.77 | 83.4 | Neo-adjuvant (N) | 2016-01-03 | 2016-01-16 | Doxorubicin + Ifosfamide | null | N | 280025292 | DOXORUBICIN + IFOSFAMIDE |
| 280003276 | 280002456 | 1.8 | 92 | Neo-adjuvant (N) | 2015-10-18 | 2015-11-07 | Cisplatin +Fluorouracil (3 wk) | N | Y | 280025292 | CISPLATIN + FLUOROURACIL |
| 280003277 | 280002457 | 1.66 | 95.5 | Neo-adjuvant (N) | 2013-08-18 | 2013-09-06 | Doxorubicin + Ifosfamide | null | N | 280025295 | DOXORUBICIN + IFOSFAMIDE |
| 280003278 | 280002458 | 1.47 | 76.6 | Neo-adjuvant (N) | 2015-03-26 | 2015-04-09 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280025300 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003279 | 280002459 | 1.67 | 102.8 | Curative (C) | 2015-07-04 | 2015-07-17 | CETUXIMAB + RT | N | Y | 280025303 | CETUXIMAB + RT |
| 280003280 | 280002460 | 1.73 | 92 | Neo-adjuvant (N) | 2017-10-12 | 2017-10-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025304 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003281 | 280002461 | 1.79 | 88.9 | Neo-adjuvant (N) | 2015-09-03 | 2015-10-29 | CISPLATIN + FLUOROURACIL | N | N | 280025305 | CISPLATIN + FLUOROURACIL |
| 280003282 | 280007274 | 1.89 | 0 | Neo-adjuvant (N) | 2016-01-20 | 2016-01-25 | Doxorubicin + Ifosfamide | N | N | 280025308 | DOXORUBICIN + IFOSFAMIDE |
| 280003283 | 280002462 | 1.76 | 109.4 | Palliative (P) | 2014-11-06 | 2014-11-21 | Doxorubicin + Ifosfamide | N | N | 280025310 | DOXORUBICIN + IFOSFAMIDE |
| 280003284 | 280002463 | 1.55 | 109.4 | Neo-adjuvant (N) | 2016-02-29 | 2016-03-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025311 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003285 | 280002464 | 1.58 | 62 | Palliative (P) | 2013-10-16 | 2013-10-27 | Doxorubicin + Ifosfamide | 02 | null | 280025312 | DOXORUBICIN + IFOSFAMIDE |
| 280003286 | 280002465 | 1.74 | 64.2 | Adjuvant (A) | 2014-07-06 | 2014-07-06 | Doxorubicin + Ifosfamide | 02 | null | 280025313 | DOXORUBICIN + IFOSFAMIDE |
| 280003287 | 280002466 | 1.61 | 114 | Neo-adjuvant (N) | null | 2014-10-03 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025314 | CISPLATIN + FLUOROURACIL |
| 280003288 | 280002467 | null | null | Neo-adjuvant (N) | 2017-09-06 | 2017-09-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025318 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003289 | 280002468 | 1.71 | 68.55 | Neo-adjuvant (N) | 2016-08-24 | 2016-09-12 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280025322 | CISPLATIN + FLUOROURACIL |
| 280003290 | 280002469 | 1.85 | 57.2 | Neo-adjuvant (N) | 2017-10-09 | 2017-10-30 | Doxorubicin + Ifosfamide | N | N | 280025323 | DOXORUBICIN + IFOSFAMIDE |
| 280003291 | 280002470 | 1.59 | 90.2 | Curative (C) | null | 2016-06-06 | CISPLATIN + FLUOROURACIL | null | null | 280025324 | CISPLATIN + FLUOROURACIL |
| 280003292 | 280002471 | 1.69 | 85.9 | Neo-adjuvant (N) | 2015-07-23 | 2015-07-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025326 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003293 | 280002471 | 2 | 81.1 | Neo-adjuvant (N) | 2013-08-22 | 2013-08-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280025326 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003294 | 280002472 | 1.61 | 72.4 | Palliative (P) | 2013-01-16 | 2014-03-12 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025328 | DOXORUBICIN + IFOSFAMIDE |
| 280003295 | 280002473 | 1.8 | 84.2 | Neo-adjuvant (N) | 2016-09-01 | 2016-09-01 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280025330 | CISPLATIN + FLUOROURACIL |
| 280003296 | 280002474 | 1.72 | 89.1 | Curative (C) | 2016-12-17 | 2017-01-16 | Cetuximab + Radiotherapy Maint | N | Y | 280025331 | CETUXIMAB + RT |
| 280003297 | 280002474 | 1.8 | 66.6 | Neo-adjuvant (N) | 2013-10-25 | 2013-11-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025331 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003298 | 280002475 | 1.63 | 0 | Curative (C) | null | 2014-03-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025336 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003299 | 280002476 | 1.8 | 65.2 | Curative (C) | 2016-10-30 | 2016-11-01 | CETUXIMAB + RT | 02 | null | 280025337 | CETUXIMAB + RT |
| 280003300 | 280002477 | null | 139 | Curative (C) | 2016-04-12 | 2016-04-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025338 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003301 | 280002478 | 1.83 | 59 | Neo-adjuvant (N) | 2016-04-13 | 2016-04-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025339 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003302 | 280002479 | 1.47 | 68.3 | Not known (9) | 2016-03-22 | 2016-03-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025342 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003303 | 280002480 | 1.74 | 90 | Disease modification (D) | 2017-09-11 | 2017-09-11 | DOXORUBICIN + IFOSFAMIDE | 2 | null | 280025343 | DOXORUBICIN + IFOSFAMIDE |
| 280003304 | 280002481 | null | 61.6 | Curative (C) | 2016-03-06 | 2016-03-13 | Cetuximab + Radiotherapy Load | Y | Y | 280025345 | CETUXIMAB + RT |
| 280003305 | 280002482 | 1.7 | 94 | Curative (C) | 2017-03-04 | 2017-03-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025348 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003306 | 280002483 | null | null | Curative (C) | 2014-11-17 | 2014-11-22 | CETUXIMAB + RT | N | null | 280025349 | CETUXIMAB + RT |
| 280003307 | 280007277 | 1.8 | 66.9 | Neo-adjuvant (N) | 2018-01-27 | 2018-02-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 280025350 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003308 | 280009720 | 1.55 | 74.4 | Curative (C) | 2014-03-04 | 2014-03-04 | Cetuximab + Radiotherapy Maint | 2 | null | 280025351 | CETUXIMAB + RT |
| 280003309 | 280009720 | 1.78 | 74.2 | null | 2017-11-14 | 2017-11-16 | CETUXIMAB + RT | 2 | N | 280025351 | CETUXIMAB + RT |
| 280003310 | 280002484 | null | 74 | Neo-adjuvant (N) | 2013-04-01 | 2013-04-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025354 | CISPLATIN + DOCETAXEL + FLUOROURACIL |